Baipharm
ChemLinked
Market
Chemical
Food
Cosmetic
BaiPharm
Agrochemical
Japan
LOG IN
SIGN UP
LOG IN
Home
News
Insights
Database
Events
Webinars
Offline Events
Services
Home
News
Insights
Database
Drug Catalog
ChP Standards
Events
Webinars
Offline Events
Services
Search
Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
All
Interpretation
Report
Q&A
All
Interpretation
Report
Q&A
Topic
Regulation
CDE Guideline
Law & Regulation
Pharmacopoeia
Reference Listed Drug (RLD)
Hot topic
Bioequivalence (BE)
Clinical Trial
CMC
CRO
DMF
Drug Registration
E-commerce
GCP
GLP
GMP
GSP
License in/out
MAH
Marketing Approval
New Drug
Pharmacovigilance
Post-market
Priority Review and Approval
Real World Data
Policy
Medical Insurance
NRDL
Volume-Based Procurement
Product
API
Biological Product
Biosimilar
Excipient
Generic Drug
Innovative Drug
OTC Drug
Packaging
Apply
Cancel
Reference Listed Drug (RLD)
INTERPRETATION
How to Get China's Marketing Authorization for OTC Drugs
Sep 16, 2022
Q&A
China CDE Q&A | BE Study, Reference Listed Drug, and Quality & Therapeutic Equivalence Evaluation
Aug 30, 2022
INTERPRETATION
China Abbreviated New Drug Application (ANDA) for Generic Drugs
May 18, 2022
